a method for the treatment or prevention of a disease mediated by the alpha - 2b - adrenoceptor in a mammal . the method includes administering to the mammal an effective amount of a selective ( alpha - 2b - adrenoceptor antagonist , where the antagonist is a compound selected from the group consisting of compounds a , b , c , d and e disclosed in scheme i , or a pharmaceutically acceptable salt of the compound .